| dc.contributor.author | Dane, Faysal | |
| dc.contributor.author | Yumuk, Perran Fulden | |
| dc.contributor.author | Turhal, Nazım Serdar | |
| dc.contributor.author | Ekenel, Meltem | |
| dc.contributor.author | Başaran, Gül | |
| dc.contributor.author | İyikesici, Mehmet Salih | |
| dc.contributor.author | Tecimer, Coşkun | |
| dc.date.accessioned | 2019-06-27T08:00:54Z | |
| dc.date.available | 2019-06-27T08:00:54Z | |
| dc.date.issued | 2004 | |
| dc.identifier.issn | 0732-183X | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12469/153 | |
| dc.description.abstract | [Abstract Not Available] | en_US] |
| dc.language.iso | eng | en_US |
| dc.publisher | AMER SOC CLINICAL ONCOLOGY | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | N/A | en_US |
| dc.title | FOLFOX4 in metastatic colorectal cancer (MCRC) patients who progressed after infusional 5-FU/irinotecan based combination regimens | en_US |
| dc.type | conferenceObject | en_US |
| dc.identifier.startpage | 301S | en_US |
| dc.identifier.endpage | 301S | |
| dc.relation.journal | Journal Of Clinical Oncology | en_US |
| dc.identifier.issue | 14 | |
| dc.identifier.volume | 22 | en_US |
| dc.identifier.wos | WOS:000223512401193 | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
